JAGUAR HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.22 USD | -1.63% |
|
-8.86% | -53.54% |
| May. 30 | Top Premarket Gainers | MT |
| May. 29 | Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences | MT |
Evolution of the average Target Price on Jaguar Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
2ff8f897bfc0b64914f.MsJDgYdfNGKuv8Lf63plXZhwG5PiouPxLLRqkO6Dj20.QI4p6PAIYTb96PO60gABJNkSI_ihwLzJS4c9o5vzzjdWrCzQzAZTLtjalw~a74e469d9fd80803b473711d1893f84d
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.22
USD
Average target price
36
USD
Spread / Average Target
+753.08%
High Price Target
36
USD
Spread / Highest target
+753.08%
Low Price Target
36
USD
Spread / Lowest Target
+753.08%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Jaguar Health, Inc.
| Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- JAGX Stock
- Consensus Jaguar Health, Inc.
